Health care-associated infections declined in 2010

Despite successes, more work is needed to ensure safe care and eliminate health care-associated infections

 

Atlanta, GA, USA (October 19, 2011) – Four common infections seen in health care facilities declined in 2010, according to the Centers for Disease Control and Prevention.  In a policy summit at the National Journal in Washington D.C., CDC staff detailed the reductions that are occurring in infection rates in U.S. hospitals. “Hospitals continue to make impressive progress in driving down certain infections in intensive care units through implementation of CDC prevention strategies,” said CDC Director Thomas R. Frieden, M.D., M.P.H. “Hospitals and state health departments need to translate this progress to other areas of health care delivery and health care infections, such as dialysis and ambulatory surgery centers, and diarrheal infections such as Clostridium difficile.”

The data were submitted by hospitals to the National Healthcare Safety Network, CDC’s health care infection monitoring system.  The number of infections reported was compared to a national baseline.  All of the infections reported have national prevention target goals as defined in the U.S. Department of Health and Human Services’ Action Plan to Prevent Healthcare-Associated Infections.

 

CDC reported for 2010:

 

  • A 33 percent reduction in central line-associated bloodstream infections: a 35 percent reduction among critical care patients and a 26 percent reduction among non-critical care patients. A central line is a tube that is placed in a large vein of a patient’s neck or chest to give important medical treatment. When not put in correctly or kept clean, central lines can become a freeway for germs to enter the body and cause serious bloodstream infections.
  • A 7 percent reduction in catheter-associated urinary tract infections throughout hospitals
  • A 10 percent reduction in surgical site infections
  • An 18 percent reduction in the number of people developing health care-associated invasive methicillin resistant Staphylococcus aureus (MRSA) infections

 

In addition, CDC saw improvement in health care provider adherence to proven infection prevention measures, such as appropriate techniques for inserting central line catheters into patients (over 94 percent adherence).  Two additional infections are currently being tracked, Clostridium difficile infections and MRSA bloodstream infections, and data on these infections will be available next year. 

 

“These successes reflect investments not only in hospital practices, but in our national and state public health capacity,” said Denise Cardo, M.D., director of CDC’s Division of Healthcare Quality Promotion.  “Preventing infections in health care saves lives and reduces health care costs.”

 

CDC has a unique role in the prevention of healthcare-associated infections in the United States. 

 

  • CDC responds to disease outbreaks in health care settings, providing health care facilities and states with resources to prevent future incidents.
  • CDC laboratories provide gold-standard testing of existing and emerging infectious threats to health care.
  • CDC guidelines are used by clinicians to prevent health care-associated infections; they form the basis for useful checklists to improve care.
  • CDC tracks health care-associated infections through the National Healthcare Safety Network, providing real-time data at the local, state, and national levels.

 

CDC supports the Partnership for Patients initiative, focused on protecting patients in America’s health care facilities through the prevention of health care-acquired conditions.  Federal initiatives, including Partnership for Patients and the HHS Action Plan to Prevent Healthcare-Associated Infections, aim to accelerate the prevention progress happening throughout the country.

 

The National Journal policy summit, titled “Spreading Success: Encouraging Best Practices in Infection Prevention” was held on Oct. 19 in Washington, D.C., and hosted by the Association for Professionals in Infection Control and Epidemiology (www.apic.org)

 

For a detailed summary of the infection data reported by CDC, please see the HHS website: http://www.hhs.gov/ash/initiatives/hai/nationaltargets/index.html

 


 

Centers for Disease Control and Prevention, 19.10.2011 (tB).

MEDICAL NEWS

Inadequate sequencing of SARS-CoV-2 variants impedes global response to COVID-19
New meta-analysis finds cannabis may be linked to development of…
New guidance on how to diagnosis and manage osteoporosis in…
Starting the day off with chocolate could have unexpected benefits
Better mental health supports for nurses needed, study finds

SCHMERZ PAINCARE

Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…
Jedes vierte Kind wünscht bessere Schmerzbehandlung
Lebensqualität von Patienten in der dauerhaften Schmerztherapie mit Opioiden verbessern

DIABETES

Bundestag berät über DMP Adipositas: DDG begrüßt dies als Teil…
Mit der Smartwatch Insulinbildung steuern
Verbände fordern bessere Ausbildung und Honorierung von Pflegekräften für Menschen…
Minimalinvasive Geräte warnen ungenügend vor Unterzuckerung
Typ-1-Diabetes und Hashimoto-Thyreoiditis treten häufig gemeinsam auf

ERNÄHRUNG

Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?
Regelmässiger Koffeinkonsum verändert Hirnstrukturen
Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren

ONKOLOGIE

Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver
Positive Ergebnisse beim fortgeschrittenen Prostatakarzinom: Phase-III-Studie zur Radioligandentherapie mit 177Lu-PSMA-617
Lymphom-News vom EHA2021 Virtual. Alle Berichte sind nun online verfügbar!
Deutsch-dänisches Interreg-Projekt: Grenzübergreifende Fortbildungskurse in der onkologischen Pflege
Sotorasib: Neues Medikament macht Lungenkrebs-Patienten Hoffnung

MULTIPLE SKLEROSE

NMOSD-Erkrankungen: Zulassung von Satralizumab zur Behandlung von Jugendlichen und Erwachsenen
Verzögerte Verfügbarkeit von Ofatumumab (Kesimpta®)
Neuer Biomarker bei Multipler Sklerose ermöglicht frühe Risikoeinschätzung und gezielte…
Multiple Sklerose beginnt oft lange vor der Diagnose
Goldstandard für Versorgung bei Multipler Sklerose

PARKINSON

Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…
Gemeinsam gegen Parkinson: bessere Therapie durch multidisziplinäre Versorgung